Integer Holdings (ITGR) Stock Price

Integer Holdings Price

NYSE·CLOSED
126.07USD+1.31 (+1.04 %)
Market closed

Revenue has compounded at 10.6% per year over the past 19 years to 1.85 B USD. Earnings per share have grown at 7.6% per year over the last 19 years. Integer Holdings's net margin stands at 5.6%, down from 7.9% several years earlier. Analysts set a median price target of 93.84 USD, implying 25.6% below the current price. Of 17 analysts, 9 rate the stock a buy — an overall Buy consensus. The stock trades about 99% above its 52-week low.

Integer Holdings stock price

Volume
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Integer Holdings over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Integer Holdings stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Integer Holdings's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Integer Holdings Stock Price History
DateInteger Holdings Price
8/6/2026126.07 USD
8/5/2026124.76 USD
8/4/2026124.53 USD
8/3/2026124.45 USD
7/31/2026121.21 USD
7/30/2026100.86 USD
7/29/2026100.38 USD
7/27/202699.47 USD
7/23/202697.50 USD
7/22/202696.56 USD
7/21/202696.31 USD
7/20/202696.09 USD
7/17/202695.42 USD
7/16/202699.62 USD
7/15/202695.56 USD
7/14/202693.31 USD
7/13/202694.79 USD
7/10/202693.68 USD
7/9/202691.95 USD
7/8/202690.65 USD
7/7/202691.90 USD
7/6/202693.18 USD
7/2/202695.14 USD
7/1/202694.57 USD
6/30/202693.45 USD
6/29/202692.94 USD
6/26/202693.89 USD
6/25/202693.12 USD
6/24/202691.38 USD
6/23/202689.54 USD
6/22/202690.39 USD
6/18/202690.97 USD
6/17/202692.47 USD
6/16/202690.50 USD
6/15/202691.27 USD
6/12/202692.13 USD
6/11/202691.30 USD
6/10/202693.77 USD
6/9/202694.10 USD
6/8/202691.89 USD
6/5/202692.74 USD
6/4/202693.29 USD
6/3/202690.15 USD
6/2/202689.98 USD
6/1/202690.75 USD
5/29/202690.51 USD
5/28/202689.67 USD
5/27/202689.68 USD
5/26/202689.42 USD
5/22/202689.87 USD
5/21/202689.53 USD
5/20/202690.63 USD
5/19/202690.44 USD
5/18/202689.97 USD
5/15/202688.16 USD
5/14/202689.82 USD
5/13/202689.39 USD
5/12/202684.98 USD
5/11/202684.85 USD
5/8/202688.12 USD
5/7/202687.92 USD
5/6/202686.29 USD
5/5/202685.85 USD
5/4/202683.95 USD
5/1/202684.03 USD
4/30/202688.51 USD
4/29/202683.67 USD
4/28/202684.64 USD
4/27/202685.35 USD
4/24/202686.02 USD
4/22/202685.16 USD
4/21/202685.62 USD
4/20/202689.32 USD
4/17/202690.20 USD
4/16/202688.37 USD
4/15/202687.94 USD
4/14/202688.63 USD
4/13/202687.73 USD
4/10/202685.11 USD
4/9/202686.67 USD
4/8/202687.48 USD
4/7/202685.11 USD
4/6/202685.63 USD
4/2/202686.85 USD
4/1/202686.44 USD
3/31/202688.00 USD
3/30/202685.16 USD
3/27/202685.33 USD
3/26/202686.83 USD
3/25/202686.76 USD
3/24/202686.19 USD
3/23/202685.33 USD
3/20/202684.10 USD
3/19/202684.36 USD
3/18/202684.36 USD
3/17/202687.21 USD
3/16/202684.12 USD
3/13/202682.98 USD
3/12/202683.30 USD
3/11/202685.47 USD
3/10/202683.28 USD
3/9/202685.38 USD
3/6/202684.03 USD
3/5/202685.23 USD
3/4/202686.03 USD
3/3/202686.75 USD
3/2/202686.34 USD
2/27/202686.68 USD
2/26/202686.77 USD
2/25/202686.50 USD
2/24/202687.10 USD
2/23/202685.76 USD
2/20/202684.85 USD
2/19/202683.00 USD
2/18/202686.48 USD
2/17/202687.66 USD
2/13/202685.92 USD
2/12/202685.36 USD
2/11/202687.18 USD
2/10/202686.15 USD
2/9/202685.46 USD
2/6/202686.45 USD
2/5/202685.23 USD
2/4/202685.52 USD
2/3/202686.04 USD
2/2/202685.55 USD
1/30/202686.86 USD
1/29/202686.47 USD
1/28/202685.90 USD
1/27/202685.79 USD
1/26/202686.24 USD
1/23/202686.24 USD
1/22/202685.54 USD
1/21/202687.00 USD
1/20/202685.15 USD
1/16/202685.78 USD
1/15/202685.28 USD
1/14/202684.70 USD
1/13/202682.74 USD
1/12/202683.57 USD
1/9/202684.31 USD
1/8/202682.79 USD
1/7/202680.88 USD
1/6/202680.81 USD
1/5/202679.72 USD
1/2/202676.78 USD
12/31/202578.43 USD
12/30/202578.34 USD
12/29/202578.53 USD
12/26/202578.88 USD
12/24/202578.71 USD
12/23/202577.77 USD
12/22/202579.23 USD
12/19/202578.58 USD
12/18/202578.52 USD
12/17/202575.56 USD
12/16/202573.90 USD
12/15/202573.09 USD
12/12/202572.72 USD
12/11/202572.34 USD
12/10/202571.95 USD
12/9/202571.60 USD
12/8/202569.13 USD
12/5/202569.84 USD
12/4/202570.62 USD
12/3/202569.88 USD
12/2/202570.26 USD
12/1/202571.75 USD
11/28/202572.18 USD
11/26/202572.04 USD
11/25/202571.43 USD
11/24/202571.22 USD
11/21/202570.00 USD
11/20/202568.13 USD
11/19/202567.66 USD
11/18/202567.75 USD
11/17/202567.10 USD
11/14/202569.49 USD
11/13/202568.05 USD
11/12/202569.51 USD
11/11/202569.82 USD
11/10/202568.76 USD
11/7/202568.26 USD
11/6/202566.64 USD
11/5/202568.14 USD
11/4/202568.61 USD
11/3/202566.71 USD
10/31/202564.57 USD
10/30/202563.51 USD
10/29/202565.31 USD
10/28/202568.00 USD
10/27/202570.01 USD
10/24/202572.92 USD
10/23/202574.00 USD
10/22/2025109.11 USD
10/21/2025107.94 USD
10/20/2025107.37 USD
10/17/2025104.83 USD
10/16/2025103.12 USD
10/15/2025103.80 USD
10/14/2025103.97 USD
10/13/2025102.10 USD
10/10/2025100.23 USD
10/9/2025103.40 USD
10/8/2025105.36 USD
10/7/2025103.72 USD
10/6/2025105.38 USD
10/3/2025105.05 USD
10/2/2025103.09 USD
10/1/2025102.92 USD
9/30/2025103.33 USD
9/29/2025101.12 USD
9/28/2025101.12 USD
9/25/2025101.50 USD
9/24/2025101.77 USD
9/23/2025103.16 USD
9/22/2025103.66 USD
9/19/2025103.31 USD
9/18/2025104.06 USD
9/17/2025102.69 USD
9/16/2025103.07 USD
9/15/2025100.19 USD
9/12/2025101.37 USD
9/11/2025104.23 USD
9/10/2025102.47 USD
9/9/2025105.52 USD
9/8/2025106.22 USD
9/5/2025106.69 USD
9/4/2025106.60 USD
9/3/2025105.84 USD
9/2/2025106.97 USD
8/29/2025107.87 USD
8/28/2025107.38 USD
8/27/2025108.07 USD
8/26/2025108.46 USD
8/25/2025108.79 USD
8/22/2025110.59 USD
8/21/2025106.83 USD
8/20/2025107.30 USD
8/19/2025106.27 USD
8/18/2025105.54 USD
8/15/2025106.80 USD
8/14/2025106.77 USD
8/13/2025109.58 USD
8/12/2025107.33 USD
8/11/2025105.40 USD
Access this data via the Eulerpool API
Get Free API Key

Integer Holdings Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2022
1.33 B USD
130.85 M USD
66.38 M USD
Jan 1, 2023
1.56 B USD
163.32 M USD
90.65 M USD
Jan 1, 2024
1.72 B USD
208.24 M USD
119.90 M USD
Jan 1, 2025
1.85 B USD
209.27 M USD
102.76 M USD
Jan 1, 2026 (e)
1.82 B USD
200.27 M USD
216.56 M USD
Jan 1, 2027 (e)
1.93 B USD
212.23 M USD
242.72 M USD
Jan 1, 2028 (e)
2.03 B USD
223.30 M USD
258.95 M USD
Jan 1, 2029 (e)
2.21 B USD
243.91 M USD
294.36 M USD

Integer Holdings Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 9, 2026, 12:56 PM
 
REVENUEB USD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM USD
EBITM USD
EBIT MARGIN%
NET INCOMEM USD
NET INCOME GROWTH%
SHARESM
2014201520162017201820192020202120222023202420252026e2027e2028e2029e
0.690.801.081.141.221.261.071.221.331.561.721.851.821.932.032.21
3.6216.4534.385.676.953.54-14.7113.799.0116.8310.357.58-1.636.005.199.23
33.6232.2531.3531.1629.7928.2226.5627.5226.0026.4326.8623.0223.0223.0223.0223.02
231.00258.00337.00354.00362.00355.00285.00336.00346.00411.00461.00425.00418.09443.19466.21509.26
75.0013.0092.00155.00160.00157.00103.00135.00130.00163.00208.00209.00200.00212.00223.00243.00
10.921.638.5613.6413.1712.489.6011.069.7710.4812.1211.3211.0111.0111.0110.99
55.00-7.005.0066.00167.0096.0077.0096.0066.0090.00119.00102.00216.00242.00258.00294.00
52.78-112.73-171.431,220.00153.03-42.51-19.7924.68-31.2536.3632.22-14.29111.7612.046.6113.95
26.0729.1831.2532.3833.0333.0933.1333.2833.4433.9936.2435.1435.1435.1435.1435.14
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Integer Holdings generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Integer Holdings retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Integer Holdings's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Integer Holdings has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Integer Holdings's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Integer Holdings stock margins

The Integer Holdings margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Integer Holdings. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Integer Holdings.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
27.60 %
11.11 %
7.93 %
Jan 1, 2022
26.04 %
9.83 %
4.99 %
Jan 1, 2023
26.45 %
10.50 %
5.83 %
Jan 1, 2024
26.87 %
12.13 %
6.98 %
Jan 1, 2025
23.06 %
11.33 %
5.57 %
Jan 1, 2026 (e)
23.06 %
11.02 %
11.92 %
Jan 1, 2027 (e)
23.06 %
11.02 %
12.61 %
Jan 1, 2028 (e)
23.06 %
11.02 %
12.78 %

Integer Holdings Stock Revenue, EBIT, Earnings per Share

The Integer Holdings earnings per share therefore indicates how much revenue Integer Holdings has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
36.69 USD
4.08 USD
2.91 USD
Jan 1, 2022
39.81 USD
3.91 USD
1.99 USD
Jan 1, 2023
45.77 USD
4.81 USD
2.67 USD
Jan 1, 2024
47.36 USD
5.75 USD
3.31 USD
Jan 1, 2025
52.54 USD
5.95 USD
2.92 USD
Jan 1, 2026 (e)
51.04 USD
5.70 USD
6.08 USD
Jan 1, 2027 (e)
54.09 USD
6.04 USD
6.82 USD
Jan 1, 2028 (e)
56.91 USD
6.35 USD
7.28 USD

Integer Holdings business model & stock analysis

Integer Holdings Corp is a globally leading medical technology company that provides a wide range of products and services to customers in various fields. The company was founded in 1979 by a man named Donald M. Stelling to develop medical devices. The company has since grown significantly and has become one of the leading providers of medical technology products. Its business model is based on providing high-quality and innovative products tailored to the needs of customers. Integer Holdings Corp is divided into four business segments. The first segment is Medical Devices, where solutions are developed for patients and medical professionals. This includes the production of catheters, medical pumps, and precision measurement devices, which play an important role in the medical care of patients. The segment specializes in the development of customized solutions for OEM manufacturers. The second segment is Power Solutions, where high-quality batteries, chargers, and power packs are manufactured for a wide range of medical devices. These batteries are designed for a long lifespan and ensure reliable power supply for medical devices. In the third segment, Advanced Surgical, innovative solutions for surgery are developed, such as suction and cutting devices for minimally invasive procedures. The modern surgical instruments offer high precision and are tailored to the needs of patients, surgeons, and clinics. The fourth and final segment is Cardio & Vascular, where products for the treatment of cardiovascular diseases are manufactured. This includes stents, balloon catheters, and pacemakers, among others. They assist doctors in monitoring and regulating the condition of patients. Overall, the company offers a wide range of products that are essential for the medical care of patients and the work of clinic staff and medical professionals. Integer Holdings Corp is committed to meeting the needs of its customers through innovative solutions. The company also has a strong commitment to quality and safety. It maintains strict controls and systems to ensure that all products meet the highest standards. Integer Holdings Corp is also dedicated to sustainable manufacturing and environmentally friendly disposal of medical technology. Overall, Integer Holdings Corp is a leading provider of medical technology products, distinguished by its innovative and customer-oriented business model. With its solutions in the Medical Devices, Power Solutions, Advanced Surgical, and Cardio & Vascular segments, the company ensures that patients and medical professionals always have access to the best technologies and products to ensure successful treatment of diseases and injuries.

Integer Holdings SWOT Analysis

Strengths

Integer Holdings Corp has a strong market position and is a leading player in the medical device industry.

The company has a diverse product portfolio, offering a wide range of innovative and high-quality medical devices.

Integer Holdings Corp enjoys strong brand recognition and has established longstanding relationships with key customers.

The company has a robust distribution network, allowing it to reach customers effectively and efficiently.

Weaknesses

Integer Holdings Corp is highly dependent on a few key customers for a significant portion of its revenue.

The company faces regulatory and compliance challenges in the constantly evolving healthcare industry.

Integer Holdings Corp may experience supply chain disruptions and cost fluctuations due to reliance on third-party suppliers.

The company's profitability is susceptible to changes in healthcare policies and reimbursement rates.

Opportunities

The global medical device market is expected to grow due to increasing healthcare expenditure and advancements in technology.

Integer Holdings Corp can expand its product offerings by investing in research and development to capitalize on emerging healthcare trends.

The company can explore new market segments and geographic regions to diversify its revenue sources.

Integer Holdings Corp can leverage partnerships and collaborations to expand its market reach and accelerate innovation.

Threats

Intense competition in the medical device industry may impact Integer Holdings Corp's market share and pricing power.

Shifts in customer preferences and demand patterns could negatively affect the company's sales and profitability.

Stringent regulatory requirements and potential litigation pose risks to the company's operations and financial performance.

Global economic uncertainties and fluctuations in currency exchange rates may impact Integer Holdings Corp's international operations.

Integer Holdings Employees

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Integer Holdings Employees
Details
Date
Integer Holdings Employees
Jan 1, 2018
- Employees
Jan 1, 2019
- Employees
Jan 1, 2020
- Employees
Jan 1, 2021
- Employees
Jan 1, 2022
- Employees
Jan 1, 2023
- Employees
Jan 1, 2024
- Employees
Jan 1, 2025
- Employees

Integer Holdings Segments

Integer Holdings Revenue by Segment (1/3)

  • 3 Years

  • 5 Years

  • Max

Cardio & Vascular
Cardiac Rhythm Management & Neuromodulation
Cardiac & Neuromodulation
Advanced Surgical, Orthopedics & Portable Medical
Other Markets
Details
Date
Cardio & Vascular
Cardiac Rhythm Management & Neuromodulation
Cardiac & Neuromodulation
Advanced Surgical, Orthopedics & Portable Medical
Other Markets
Jan 1, 2016
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2016
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2017
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2020
569.95 M USD
0.00 USD
346.24 M USD
121.79 M USD
0.00 USD
Jan 1, 2021
626.01 M USD
0.00 USD
446.57 M USD
110.04 M USD
0.00 USD
Jan 1, 2022
699.47 M USD
532.58 M USD
0.00 USD
97.50 M USD
0.00 USD
Jan 1, 2023
836.34 M USD
610.58 M USD
0.00 USD
106.42 M USD
0.00 USD
Jan 1, 2025
1.11 B USD
668.80 M USD
0.00 USD
0.00 USD
77.75 M USD

Integer Holdings Revenue by Segment (2/3)

  • 3 Years

  • 5 Years

  • 10 Years

  • Max

Cardio And Vascular
Advanced Surgical, Orthopaedics, and Portable Medical
Cardiac/Neuromodulation
Cardiac Neuromodulation
Electrochem
Orthopaedic
Energy
Portable Medical
Vascular
Other Products and Services
Details
Date
Cardio And Vascular
Advanced Surgical, Orthopaedics, and Portable Medical
Cardiac/Neuromodulation
Cardiac Neuromodulation
Electrochem
Orthopaedic
Energy
Portable Medical
Energy Environmental
Vascular
Other Products and Services
Other Electrochem
Jan 1, 2016
568.51 M USD
392.78 M USD
389.40 M USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2016
143.26 M USD
243.39 M USD
356.06 M USD
0.00 USD
59.45 M USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2017
536.79 M USD
439.81 M USD
428.35 M USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2020
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2021
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2022
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2023
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2025
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD

Integer Holdings Revenue by Segment (3/3)

  • 3 Years

  • 5 Years

  • 10 Years

  • Max

Reportable Segment
Medical
Medical Segment
Greatbatch Medical
Lake Region Medical
Non-Medical Segment
Non-Medical
QiG
Details
Date
Reportable Segment
Medical
Medical Segment
Greatbatch Medical
Implantable Medical
Electrochem
Lake Region Medical
Non-Medical Segment
Non-Medical
QiG
Jan 1, 2016
0.00 USD
0.00 USD
1.35 B USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
41.68 M USD
0.00 USD
0.00 USD
Jan 1, 2016
0.00 USD
0.00 USD
0.00 USD
649.98 M USD
0.00 USD
0.00 USD
139.82 M USD
0.00 USD
0.00 USD
13.57 M USD
Jan 1, 2017
0.00 USD
0.00 USD
1.40 B USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
56.97 M USD
0.00 USD
0.00 USD
Jan 1, 2020
0.00 USD
1.04 B USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
35.46 M USD
0.00 USD
Jan 1, 2021
0.00 USD
1.18 B USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
38.45 M USD
0.00 USD
Jan 1, 2022
0.00 USD
1.33 B USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
46.55 M USD
0.00 USD
Jan 1, 2023
0.00 USD
1.55 B USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
43.33 M USD
0.00 USD
Jan 1, 2025
1.85 B USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD

Integer Holdings Revenue by Region

  • 3 Years

  • 5 Years

  • 10 Years

  • Max

United States
International
Costa Rica
PUERTO RICO
Ireland
BELGIUM
United Kingdom & Ireland
Details
Date
United States
International
Costa Rica
PUERTO RICO
Ireland
BELGIUM
United Kingdom Ireland
United Kingdom & Ireland
Jan 1, 2018
687.26 M USD
319.21 M USD
62.04 M USD
146.50 M USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2019
698.47 M USD
341.34 M USD
63.63 M USD
154.64 M USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2020
596.80 M USD
321.74 M USD
58.85 M USD
96.05 M USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2021
671.50 M USD
372.44 M USD
66.98 M USD
110.16 M USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2022
762.13 M USD
423.74 M USD
76.14 M USD
114.08 M USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2023
897.43 M USD
501.25 M USD
89.57 M USD
108.42 M USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2024
938.68 M USD
516.17 M USD
124.69 M USD
137.06 M USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2025
979.81 M USD
469.89 M USD
173.52 M USD
131.26 M USD
99.16 M USD
0.00 USD
0.00 USD
0.00 USD

Integer Holdings Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Integer Holdings historical P/E ratio, EBIT multiple, and P/S ratio

Integer Holdings annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Integer Holdings shares outstanding

The number of shares of Integer Holdings was 35.14 M in 2025. This indicates how many shares Integer Holdings is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
33.28 M Stocks
Jan 1, 2022
33.44 M Stocks
Jan 1, 2023
33.99 M Stocks
Jan 1, 2024
36.24 M Stocks
Jan 1, 2025
35.14 M Stocks
Jan 1, 2026 (e)
35.14 M Stocks
Jan 1, 2027 (e)
35.14 M Stocks
Jan 1, 2028 (e)
35.14 M Stocks

Current Integer Holdings forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
5.75 %
Buy
52.94 % (9)
Hold
47.06 % (8)
Sell
0.00 % (0)
12M Price Target
93.84
Last Price
125.27
Currency
USD
12M Return Potential
-25.09 %
LTM Return
0 %

Integer Holdings Analyst Rating Actions

DateFirmActionRatingReliability
7/16/2026
Truist Securities
Truist Securities
MaintainedBuy–
7/8/2026
Citigroup
Citigroup
MaintainedNeutral48
5/28/2026
Citigroup
Citigroup
MaintainedNeutral48
5/13/2026
Oppenheimer
Oppenheimer
UpgradePerformOutperform65
5/1/2026
Piper Sandler
Piper Sandler
MaintainedOverweight51
5/1/2026
Citigroup
Citigroup
MaintainedNeutral48
2/20/2026
Wells Fargo
Wells Fargo
MaintainedEqual Weight56
2/20/2026
Truist Securities
Truist Securities
MaintainedBuy–
2/20/2026
Citigroup
Citigroup
MaintainedNeutral48
2/20/2026
Benchmark
Benchmark
UpgradeHoldBuy71

Eulerpool Reliability Score (0–100): measures how often a firm’s bullish or bearish calls were directionally correct three months later, blended with the average return following its calls. Every rating we record is stored permanently and scores update continuously; firms with fewer than 3 measured calls are not scored yet.

Integer Holdings Earnings Calls

2025

Integer Holdings Earnings Estimates & Surprises

DateEPS estimateEPS ActualRevenue EstimatePrice reactionQuarterly report
8/6/20261.44USD-459.51 MUSD-2026 Q2
4/30/20261.21USD-435.01 MUSD-2026 Q1
2/19/20261.73USD-471.98 MUSD-2025 Q4
4/25/20241.17USD-413.09 MUSD-2024 Q1
2/14/20241.35USD-412.78 MUSD-2023 Q4
7/26/20230.93USD-360.32 MUSD-2023 Q2
4/26/20230.72USD-334.95 MUSD-2023 Q1
2/15/20231.09USD-361.31 MUSD-2022 Q4
10/27/20220.91USD-350.31 MUSD-2022 Q3
7/28/20220.98USD-348.72 MUSD-2022 Q2
...

EESG©

Eulerpool ESG Scorecard© for the Integer Holdings stock

40/100
14
Environment
81
Social
25
Governance
E

Environment

20
Scope 1 - Direct Emissions6,812.977
Scope 2 - Indirect emissions from purchased energy51,984.73
Scope 3 - Indirect emissions within the value chain—
Total CO₂ emissions58,797.707
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather—
Pesticides—
Palm Oil—
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees48
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Integer Holdings shareholder structure

% Name
14.90656%
BLACKROCK, INC.
BLACKROCK, INC.
13.67641%
BlackRock Institutional Trust Company, N.A.
BlackRock Institutional Trust Company, N.A.
10.89438%
The Vanguard Group, Inc.
The Vanguard Group, Inc.
5.75087%
VANGUARD PORTFOLIO MANAGEMENT LLC
VANGUARD PORTFOLIO MANAGEMENT LLC
5.53220%
INVESCO LTD.
INVESCO LTD.
4.32456%
MORGAN STANLEY
MORGAN STANLEY
...

Integer Holdings Beneficial Ownership Filings (SEC 13D/G)

Free Float
98.5%
Float Shares
-
Shares Outstanding
-
StakeHolderFiling
16.90%
(1) BlackRock, Inc.
(1) BlackRock, Inc.
SEC ↗
14.70%
BlackRock, Inc.
BlackRock, Inc.
SEC ↗
11.40%
Franklin Resources, Inc. (13-2670991)
Franklin Resources, Inc. (13-2670991)
SEC ↗
10.86%
The Vanguard Group - 23-1945930
The Vanguard Group - 23-1945930
SEC ↗
10.00%
Abigail P. Johnson
Abigail P. Johnson
SEC ↗
9.64%
KKR Group Limited
KKR Group Limited
SEC ↗
7.54%
BlackRock for purposes of Schedule 13G filings.
BlackRock for purposes of Schedule 13G filings.
SEC ↗
6.03%
Vanguard Portfolio Management
Vanguard Portfolio Management
SEC ↗
5.90%
Franklin Resources, Inc.
Franklin Resources, Inc.
SEC ↗
5.80%
30-0447847
30-0447847
SEC ↗

Integer Holdings Executives and Management Board

17 members · avg. age 61 · 29 % women

DS

Mr. Diron Smith (52)

Chief Financial Officer, Executive Vice President

2.47 M USD

Management

PK

Mr. Payman Khales (55)

President, Chief Executive Officer, Director · since 2018

1.98 M USD
JH

Mr. John Harris (65)

Executive Vice President - Global Operations and Manufacturing Strategy · since 2024

1.87 M USD
JS

Mr. Jim Stephens (51)

President - Cardiac Rhythm Management & Neuromodulation

1.60 M USD
KT

Mr. Kirk Thor (61)

Executive Vice President, Chief Human Resources Officer

1.34 M USD
MC

Ms. Margaret Carthy (61)

Executive Vice President - Quality and Regulatory Affairs

–
AS

Mr. Andrew Senn (43)

Senior Vice President - Strategy, Business Development and Investor Relations

–

Board of Directors

PB

Ms. Pamela Bailey (76)

Independent Chairman of the Board

379,979.00 USD
JH

Mr. James Hinrichs (57)

Independent Director

294,114.00 USD
JH

Ms. Jean Hobby (64)

Independent Director

279,206.00 USD
DS

Mr. Donald Spence (71)

Independent Director

279,077.00 USD
SA

Ms. Sheila Antrum (66)

Independent Director

269,924.00 USD
AJ

Mr. Alvin Jeffers (51)

Independent Director

269,924.00 USD

Integer Holdings Supply Chain

Integer Holdings Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite
7 companies
#Nameβ 1YTrend
1
Medtronic
Customer·Health Care Equipment & Supplies·IE
0.21
0.55
-0.07
0.30
0.87
0.79
0.46
2
Abbott Laboratories
Customer·Health Care Equipment & Supplies·US
0.27
0.40
0.37
0.51
-0.10
0.60
-0.07
3
Boston Scientific
Customer·Health Care Equipment & Supplies·US
0.29
0.58
0.33
-0.18
0.33
0.56
0.22
4
SailPoint Technologies
Supplier·Software·US
0.73
-0.04
-0.24
0.12
-0.01
0.44
-0.01
#Nameβ 1YTrend
1
VITZROCELL
Supplier·Customer·Electrical Equipment·KR
-0.46
0.53
0.47
0.14
0.75
-0.47
1.58
2
Kinaxis
Supplier·Software·CA
-0.15
0.24
-0.02
0.56
0.36
-0.43
—
3
Nevro
Supplier·Customer·Health Care Equipment & Supplies·US
0.59
0.82
0.53
0.67
0.80
-0.02
—

Frequently asked questions about Integer Holdings

The business model of Integer Holdings Corp, a leading medical device outsource manufacturer, revolves around providing innovative solutions and advanced technologies to the healthcare industry. Integer offers a comprehensive range of products and services, including advanced surgical instruments, cardiac rhythm management devices, neuromodulation and spinal cord stimulation systems, and various other medical devices. By leveraging their extensive expertise, state-of-the-art facilities, and strong industry partnerships, Integer caters to the increasing demand for high-quality healthcare solutions. With a focus on driving improvements and enhancing patient outcomes, Integer Holdings Corp remains committed to delivering exceptional medical device manufacturing services worldwide.

Integer Holdings Corp is primarily active in the medical technology industry.

The main competitors of Integer Holdings Corp in the market include Medtronic, Johnson & Johnson, and Stryker Corporation.

Integer Holdings Corp, also known as Integer, is a leading medical device outsource manufacturer based in Texas. The company has a rich history, originally founded in 1947 as Medrad, which focused on manufacturing contrast delivery systems for medical imaging procedures. In 2011, the company was acquired by Boston Scientific and was later spun off as an independent company in 2016, rebranding as Integer Holdings Corp. With over 70 years of experience, Integer has become a trusted partner in the medical device industry, offering innovative solutions and comprehensive manufacturing capabilities. Today, Integer continues to drive advancements in medical technology, delivering high-quality products to improve patient care globally.

Integer Holdings Corp, a leader in medical device outsourcing, has achieved numerous significant milestones throughout its history. The company has continuously focused on innovation, collaborating with leading healthcare organizations to develop cutting-edge solutions that address critical medical needs. Integer Holdings Corp has maintained a strong track record of delivering high-quality products and services, earning the trust of its global customers. With a commitment to manufacturing excellence and a broad portfolio of medical technologies, the company has successfully positioned itself as a trusted partner in the highly regulated healthcare industry. Integer Holdings Corp's dedication to advancing healthcare through its expertise and comprehensive offerings has solidified its position as a key player in the market.

Integer Holdings Corp is primarily present in various countries and regions, including the United States, Germany, Italy, Switzerland, France, the United Kingdom, Mexico, Singapore, and Malaysia.

Integer Holdings Corp represents values of innovation, quality, and integrity in the medical device industry. The company is committed to designing and manufacturing advanced solutions that improve patient outcomes and healthcare experiences. With a strong focus on research and development, Integer strives to create groundbreaking technologies and deliver cutting-edge products to medical professionals worldwide. As a responsible corporate citizen, Integer upholds the highest ethical standards and ensures compliance with regulatory requirements. The company's dedication to excellence and commitment to customers make Integer Holdings Corp a trusted and reliable partner in the healthcare industry.

Analysts currently set an average price target of 94.13 USD for the Integer Holdings stock (median: 93.84 USD), implying -24.9 % versus the latest price. The consensus is based on 17 analyst ratings.

Integer Holdings Analyst Price Targets 2026

17 analysts currently rate the Integer Holdings stock: 10 recommend buying, 7 holding and 0 selling. For 2026, analysts expect Integer Holdings to generate revenue of 1.82 B USD and earnings per share of 6.16 USD.

Integer Holdings Analyst Price Targets 2026

Converted at the current exchange rate, the Integer Holdings share trades at 109.17 EUR (126.07 USD).

The Integer Holdings share (ITGR) is listed on 4 stock exchanges, including: NYSE (ITGR), Frankfurt (WGB.F), München (WGB.MU), SIX (Zürich) (WGB.SW).

Integer Holdings Corp is a leading company in the medical technology industry. It operates globally and offers innovative solutions for a variety of medical applications. The business model of Integer Holdings Corp is based on four different business segments: Cardio & Vascular, Neuromodulation, Advanced Surgical, and Orthopedics.

The expected revenue of Integer Holdings is 1.82 B USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Integer Holdings is 216.56 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Integer Holdings is currently 20.46. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Integer Holdings stock.

The price-to-sales ratio (P/S) of Integer Holdings is currently 2.44. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Integer Holdings stock.

The Eulerpool Quality Score for Integer Holdings is 6/10.

The ISIN of Integer Holdings is US45826H1095. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Integer Holdings is A2AMZW. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Integer Holdings is ITGR. The ticker symbol is used to trade Integer Holdings shares on the stock exchange.

Integer Holdings paid dividends every year for the past 0 years.

Integer Holdings is assigned to the 'Health' sector.

The dividends of Integer Holdings are distributed in USD.

All fundamentals and in-depth analysis of Integer Holdings

Our stock analysis for Integer Holdings stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Integer Holdings. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Integer Holdings Stock
Integer Holdings Revenue→
Integer Holdings Stock
Integer Holdings Net Income→
Integer Holdings Stock
Integer Holdings P/E→
Integer Holdings Stock
Integer Holdings P/S→
Integer Holdings Stock
Integer Holdings EBIT→
Integer Holdings Stock
Integer Holdings Dividend→
Integer Holdings Stock
Integer Holdings Directors Dealings→
Integer Holdings Stock
Integer Holdings Stocks→
Integer Holdings Stock
Integer Holdings Market capitalization→
Integer Holdings Stock
Integer Holdings Debt→
Integer Holdings Stock
Integer Holdings Liabilities→
Integer Holdings Stock
Integer Holdings Equity→
Integer Holdings Stock
Integer Holdings AAQS→
Integer Holdings Stock
Integer Holdings Employees→
Integer Holdings Stock
Integer Holdings ROE→
Integer Holdings Stock
Integer Holdings ROA→
Integer Holdings Stock
Integer Holdings ROCE→
Integer Holdings Stock
Integer Holdings News→
Integer Holdings Stock
Integer Holdings Analyst Price Targets→

Health Stocks

Integra Lifesciences HoldingsIntech BiopharmIntegragenIntco Medical Technology CoIntegral DiagnosticsIntai TechnologyIntegrated Diagnostics HoldingsInsuletIntegrumInstituto de DiagnosticoIntelicare HoldingsInspireMDAll Stocks A–Z →